Rapport Therapeutics · 6 hours ago
Director, Regulatory Strategy
99 High Street, Suite 2100 , Boston, MA 02110
Full-time
Hybrid
Director/Executive
$225K/yr - $250K/yr
12+ years expRapport Therapeutics is driven by a passion for developing precision neuromedicines with the potential for fewer side effects. The Director of Regulatory Strategy will lead strategic regulatory initiatives for drug development programs, ensuring compliance and effective regulatory strategies.
BiotechnologyHealth CareLife ScienceMedicalNeurosciencePrecision Medicine
Responsibilities
Create and implement innovative and effective regulatory strategies to support the development of Rapport global drug development programs
Provide regulatory expertise and advise to cross-functional team members including clinical, CMC, clinical pharmacology, and nonclinical
Accountable for the maintenance of regulatory applications such as INDs, CTAs, NDAs, etc
Identify regulatory risks and mitigation plans
Serve as the regulatory lead on project teams
Ensure compliance with local and international submission requirements, manage CROs as applicable
Represents Rapport as the point of contact for regulatory health authorities, as assigned ensuring exemplary ethics and transparency within the company and with health authorities
Keeps current with global regulatory landscape and advises project teams on potential impact to programs
Provide mentorship and support to junior team members to foster their professional growth and development
Qualification
Required
Bachelors degree in a life science or related discipline
12+ years of experience in the pharmaceutical or biotech industry
Global drug development experience
Ability to manage competing priorities, influence and integrate within a team, manage timelines and deliver on corporate and program goals
Strong interpersonal skills and alignment with Rapport's values and company culture
Must demonstrate strong leadership and team building skills, including experience with conflict resolution and real time problem solving
Thorough understanding of the development phases within a fast-moving biopharmaceutical organization
Exceptional written and verbal communication skills
Preferred
Experience in neurology and small molecules
Experience working with DAAP or Neurology FDA Divisions
Benefits
Unlimited PTO
A lifestyle spending account
Commuting reimbursement
A pretty great benefits package
Company
Rapport Therapeutics
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
11-50 employees
Funding
Current Stage
Public CompanyTotal Funding
$500MKey Investors
Cormorant Asset ManagementThird Rock Ventures
2025-09-09Post Ipo Equity· $250M
2024-06-07IPO
2023-08-23Series B· $150M
Leadership Team
Troy Ignelzi
Chief Financial Officer
Cheryl Gault
Chief Operating Officer
Recent News
2026-01-08
Company data provided by crunchbase